Daichi Fujita

Employment

• Meiji Co., Ltd. Scientist
  2025 - Present
• Axcelead Tokyo West Partners
  2024 - 2025
• Teijin Pharma Researcher
  2019 - 2024

Education

• Kanazawa University Ph.D. in Pharmaceutical Sciences (Faculty of Pharmaceutical Sciences)
  2016 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• A Practical In Silico Method for Predicting Compound Brain Concentration-Time Profiles: Combination of PK Modeling and Machine Learning.
  Molecular pharmaceutics 2024 DOI: 10.1021/acs.molpharmaceut.4c00584
  +Save
• MicroRNAs in Apple-Derived Nanoparticles Modulate Intestinal Expression of Organic Anion–Transporting Peptide 2B1/SLCO2B1 in Caco-2 Cells
  Drug Metabolism and Disposition 2021 DOI: 10.1124/dmd.121.000380
  +Save
• Uptake Pathway of Apple-derived Nanoparticle by Intestinal Cells to Deliver its Cargo
  Pharmaceutical Research 2021 DOI: 10.1007/s11095-021-03018-8
  +Save
• Apple-Derived Nanoparticles Modulate Expression of Organic-Anion-Transporting Polypeptide (OATP) 2B1 in Caco-2 Cells
  Molecular Pharmaceutics 2018 DOI: 10.1021/acs.molpharmaceut.8b00921
  +Save
• Oral drug delivery system targeting intestinal transporters
  Drug Delivery System 2018 DOI: 10.2745/dds.33.377
  +Save
• Molecular localization and characterization of multiple binding sites of organic anion transporting polypeptide 2B1 (OATP2B1) as the mechanism for substrate and modulator dependent drug–drug interaction
  MedChemComm 2016 DOI: 10.1039/c6md00235h
  +Save
• Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride
  Drug Metabolism and Disposition 2015 DOI: 10.1124/dmd.115.066712
  +Save